News
Novo Nordisk is hedging and building its way around a global tariff war that may threaten the Wegovy maker’s plans to expand ...
Pedersen and Maggie Fick COPENHAGEN/LONDON (Reuters) - Obesity drugmaker Novo Nordisk cut its sales forecasts on Wednesday ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
As Novo Nordisk works through a period of transition in the U.S. GLP-1 drug market, sales from the company's star obesity ...
Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...
7don MSN
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
My doctor said patients have told him they were able to stop drinking and even quit cocaine use while taking Wegovy.
The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...
As summer approaches, millions of Americans are turning to weight-loss injections in hopes of shedding pounds—fast. Roughly ...
Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback